A study by Chu et al. also proved that suppressed expression of miR-15a/16 caused tamoxifen resistance in breast cancer cells by increasing the cell proliferation rate and cell cycle progression, while forced expression of miR-15a/16 re-sensitized breast cancer cells towards tamoxifen treatment by negatively inhibiting cyclin E1. The gene discussed is CCNE1; the disease is breast cancer.